January 2017

Risky addictive behavior in the workplace is costing U.S. employers $400 billion annually in lost productivity and direct health-care expenses. According to a recent Surgeon General’s Report, in 2015 more than 27 million people in the U.S. reported using illegal drugs or misusing prescription drugs, and more than 66 million... Read More

Many startup companies seek venture capital as a way to finance their growth and development. But few ─ about 2 percent ─ are actually equity investable, according to Peter Adriaens, a University of Michigan professor of environmental engineering, finance and entrepreneurship and the co-founder and CEO of Corymbus Asset Management... Read More

Angel and venture capital investors attending this year’s Michigan Growth Capital Symposium, on May 16 and 17, will get an early preview of a number of high-potential U-M spinout companies that are commercializing cutting-edge technologies developed by Michigan faculty, staff and students in the University’s research laboratories. Initially, these spinouts... Read More

For the first time, the University of Michigan will host the Coulter Investment Forum in conjunction with the 2017 Michigan Growth Capital Symposium on May 16 and 17. The annual forum, sponsored by the Wallace H. Coulter Foundation, will showcase 25 to 32 emerging companies with life-science innovations that have... Read More

Michigan has pulled ahead of other states in the race to find a cure for cancer, develop autonomous vehicles and commercialize countless high-tech innovations. However, additional local venture capital investment is sorely needed to provide the follow-on funding to attract, retain and accelerate the growth and profitability of high-potential entrepreneurial... Read More